Bafna Pharmaceuticals Ltd

Bafna Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bafna Pharmaceuticals Ltd

₹ 87.0 0.58%
25 Apr 11:36 a.m.
bafnapharma.com BSE: 532989 NSE - BE : BAFNAPH
About

Incorporated in 1981, Bafna Pharmaceuticals
Ltd manufactures finished pharmaceutical formulations[1]

Key Points

Product Profile:[1][2][3]
Company is manufacturing over 336
licensed pharmaceutical formulations
and has globally registered 78 of its
products viz. Afenac-p Tab, Afenac-th
Tab, finished solid oral and liquid oral
dosage forms of Betalactam and Non – Betalactam and Cephalosporin products

Website BSE NSE - BE
  • Market Cap ₹ 206 Cr.
  • Current Price ₹ 87.0
  • High / Low ₹ 126 / 75.9
  • Stock P/E 18.3
  • Book Value ₹ 34.8
  • Dividend Yield 0.00 %
  • ROCE 15.9 %
  • ROE 16.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 13.5% over last 3 years.
  • Debtor days have increased from 80.9 to 130 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
17.48 21.84 21.26 28.44 20.46 14.98 16.93 21.96 34.22 42.24 41.95 40.68 28.44
15.27 17.64 17.77 22.74 17.63 15.36 15.27 19.42 31.18 34.62 35.66 36.67 30.51
Operating Profit 2.21 4.20 3.49 5.70 2.83 -0.38 1.66 2.54 3.04 7.62 6.29 4.01 -2.07
OPM % 12.64% 19.23% 16.42% 20.04% 13.83% -2.54% 9.81% 11.57% 8.88% 18.04% 14.99% 9.86% -7.28%
0.04 0.31 0.17 -1.79 0.49 1.04 1.30 0.64 1.93 0.26 1.87 0.16 0.98
Interest 0.33 0.38 0.11 0.11 0.41 0.21 0.31 0.45 0.58 0.70 0.60 0.44 0.58
Depreciation 1.02 1.50 1.46 1.42 1.21 1.40 1.29 1.12 1.40 1.53 1.21 1.24 1.27
Profit before tax 0.90 2.63 2.09 2.38 1.70 -0.95 1.36 1.61 2.99 5.65 6.35 2.49 -2.94
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.96% 0.00% 0.00% 0.00%
0.90 2.64 2.09 2.38 1.70 -0.95 1.36 1.61 3.00 5.37 6.35 2.48 -2.94
EPS in Rs 0.38 1.12 0.88 1.01 0.72 -0.40 0.57 0.68 1.27 2.27 2.68 1.05 -1.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
124 167 177 100 85 65 46 44 42 71 85 115 153
105 146 156 116 82 70 81 57 41 61 73 100 137
Operating Profit 18 21 21 -16 3 -5 -35 -13 1 10 12 16 16
OPM % 15% 13% 12% -16% 3% -8% -77% -30% 3% 14% 14% 14% 10%
1 3 1 40 1 1 31 0 -23 1 -0 3 3
Interest 8 11 12 12 12 11 7 2 0 1 1 2 2
Depreciation 6 8 8 5 4 4 4 3 3 4 5 5 5
Profit before tax 5 5 2 6 -13 -19 -14 -18 -25 6 5 12 12
Tax % 61% 25% 40% -0% 3% 4% -15% -8% 0% 0% 0% 2%
2 4 1 6 -12 -18 -16 -20 -25 6 5 11 11
EPS in Rs 1.13 2.08 0.72 3.28 -6.53 -9.90 -6.95 -8.34 -106.53 2.46 2.21 4.79 4.76
Dividend Payout % 0% 29% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -4%
5 Years: 20%
3 Years: 40%
TTM: 74%
Compounded Profit Growth
10 Years: 18%
5 Years: 18%
3 Years: 100%
TTM: 116%
Stock Price CAGR
10 Years: 13%
5 Years: 57%
3 Years: -14%
1 Year: 3%
Return on Equity
10 Years: -19%
5 Years: 1%
3 Years: 13%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 18 19 19 19 19 19 24 24 2 24 24 24 24
Reserves 40 49 50 53 41 22 17 -3 49 33 38 50 59
81 91 99 64 80 82 47 46 3 15 11 23 17
69 84 54 50 45 44 40 54 17 14 17 33 36
Total Liabilities 207 243 223 185 185 167 128 121 71 86 90 130 135
70 66 63 49 47 43 40 37 35 36 39 40 41
CWIP 0 0 0 0 0 0 0 0 0 1 0 2 2
Investments 1 1 1 18 18 18 1 1 0 0 0 0 0
136 175 158 118 120 106 86 82 36 50 51 88 92
Total Assets 207 243 223 185 185 167 128 121 71 86 90 130 135

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
28 35 1 9 -3 14 -7 -1 -34 -14 10 5
-37 -6 -5 56 -1 -8 38 4 33 -5 -7 -7
-1 -11 -14 -66 4 -5 -31 -2 7 12 -5 10
Net Cash Flow -9 18 -18 -0 0 -0 0 0 6 -7 -2 8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 241 187 192 303 291 302 195 208 52 49 63 130
Inventory Days 92 63 78 66 92 118 102 122 208 154 185 129
Days Payable 216 215 116 149 169 164 265 517 229 107 113 165
Cash Conversion Cycle 117 35 155 220 214 255 31 -188 31 96 135 94
Working Capital Days 213 150 204 250 320 207 79 -16 89 172 148 150
ROCE % 11% 9% 9% -13% -0% -6% -36% -21% -3% 10% 11% 16%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
90.39% 90.40% 90.42% 90.42% 90.12% 90.00% 90.01% 89.99% 89.99% 88.73% 88.42% 88.29%
9.61% 9.60% 9.58% 9.58% 9.88% 10.00% 9.98% 10.00% 10.00% 11.27% 11.57% 11.70%
No. of Shareholders 8,3308,0687,9107,3267,2237,2757,1997,1206,9927,3547,3677,539

Documents

Announcements

Annual reports

DRHP

Credit ratings